Peter Powers

9.9k total citations · 3 hit papers
34 papers, 4.9k citations indexed

About

Peter Powers is a scholar working on Internal Medicine, Surgery and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Peter Powers has authored 34 papers receiving a total of 4.9k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Internal Medicine, 13 papers in Surgery and 12 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Peter Powers's work include Venous Thromboembolism Diagnosis and Management (15 papers), Atrial Fibrillation Management and Outcomes (10 papers) and Heparin-Induced Thrombocytopenia and Thrombosis (7 papers). Peter Powers is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (15 papers), Atrial Fibrillation Management and Outcomes (10 papers) and Heparin-Induced Thrombocytopenia and Thrombosis (7 papers). Peter Powers collaborates with scholars based in Canada, United States and Japan. Peter Powers's co-authors include M Andrew, Ruth Milner, Bosco Paes, DM Tollefsen, Michael Gent, Jack Hirsh, Mark Levine, Jacques Leclerc, Richard M. Jay and Russell D. Hull and has published in prestigious journals such as New England Journal of Medicine, JAMA and Circulation.

In The Last Decade

Peter Powers

34 papers receiving 4.6k citations

Hit Papers

A Comparison of Low-Molecular-Weight Heparin Administered... 1987 2026 2000 2013 1996 1987 1988 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter Powers Canada 26 2.9k 2.1k 1.8k 1.5k 669 34 4.9k
Dominique Mottier France 33 3.5k 1.2× 2.8k 1.3× 1.2k 0.7× 1.3k 0.8× 395 0.6× 143 5.5k
Franco Piovella Italy 34 4.7k 1.6× 3.3k 1.5× 1.3k 0.8× 1.9k 1.2× 584 0.9× 90 6.3k
Lesley Mitchell Canada 42 2.3k 0.8× 1.2k 0.6× 3.2k 1.8× 1.1k 0.7× 671 1.0× 119 5.2k
Thomas M. Hyers United States 37 3.2k 1.1× 2.3k 1.1× 850 0.5× 1.6k 1.0× 2.7k 4.0× 73 7.0k
Hervé Decousus France 33 5.6k 1.9× 3.9k 1.8× 975 0.6× 2.1k 1.4× 350 0.5× 108 6.7k
Rupert Bauersachs Germany 43 4.9k 1.7× 4.7k 2.2× 1.3k 0.7× 2.2k 1.4× 716 1.1× 228 7.5k
Richard M. Jay Canada 19 3.5k 1.2× 2.2k 1.0× 727 0.4× 1.7k 1.1× 371 0.6× 45 4.5k
Namita Sood United States 13 3.0k 1.0× 2.3k 1.1× 669 0.4× 989 0.6× 728 1.1× 42 4.2k
Neil A. Goldenberg United States 39 4.5k 1.6× 2.1k 1.0× 3.5k 2.0× 1.9k 1.3× 877 1.3× 232 7.5k
Patrick Mismetti France 33 2.9k 1.0× 2.2k 1.0× 628 0.4× 1.0k 0.7× 328 0.5× 154 4.2k

Countries citing papers authored by Peter Powers

Since Specialization
Citations

This map shows the geographic impact of Peter Powers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Powers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Powers more than expected).

Fields of papers citing papers by Peter Powers

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Powers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Powers. The network helps show where Peter Powers may publish in the future.

Co-authorship network of co-authors of Peter Powers

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Powers. A scholar is included among the top collaborators of Peter Powers based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Powers. Peter Powers is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Woods, Karen, et al.. (2004). Patient preferences for capillary vs. venous INR determination in an anticoagulation clinic: a randomized controlled trial. Thrombosis Research. 114(3). 161–165. 33 indexed citations
2.
Levine, Mark, Michael Gent, Jack Hirsh, et al.. (1996). A Comparison of Low-Molecular-Weight Heparin Administered Primarily at Home with Unfractionated Heparin Administered in the Hospital for Proximal Deep-Vein Thrombosis. New England Journal of Medicine. 334(11). 677–681. 872 indexed citations breakdown →
3.
Gent, M, J. Hirsh, J Weitz, et al.. (1996). Ardeparin (low-molecular-weight heparin) vs graduated compression stockings for the prevention of venous thromboembolism. A randomized trial in patients undergoing knee surgery.. PubMed. 156(8). 851–6. 61 indexed citations
4.
Sarabia, Alicia, Rose Hatala, Derek King, et al.. (1995). Inadequacy of intravenous heparin therapy in the initial management of venous thromboembolism. Journal of General Internal Medicine. 10(6). 342–345. 7 indexed citations
5.
Popov, Todor A., et al.. (1994). The evaluation of a cell dispersion method of sputum examination. Clinical & Experimental Allergy. 24(8). 778–783. 174 indexed citations
6.
Turpie, Alexander G.G., Michael Gent, Mark Levine, et al.. (1992). A Low-Molecular-Weight Heparinoid Compared with Unfractionated Heparin in the Prevention of Deep Vein Thrombosis in Patients with Acute Ischemic Stroke. Annals of Internal Medicine. 117(5). 353–357. 84 indexed citations
7.
Levine, Mark N., Jack Hirsh, Michael Gent, et al.. (1991). Prevention of Deep Vein Thrombosis after Elective Hip Surgery. Annals of Internal Medicine. 114(7). 545–551. 245 indexed citations
8.
Powers, Peter, Michael Gent, Richard M. Jay, et al.. (1990). A Randomized Trial of Less Intense Postoperative Warfarin or Aspirin Therapy in the Prevention of Venous Thromboembolism After Surgery for Fractured Hip. Survey of Anesthesiology. 34(2). 85–85. 1 indexed citations
9.
Kelton, John G., et al.. (1989). A prospective comparison of four techniques for measuring platelet‐associated IgG. British Journal of Haematology. 71(1). 97–105. 45 indexed citations
11.
Andrew, M, Bosco Paes, Ruth Milner, et al.. (1988). Development of the human coagulation system in the healthy premature infant. Blood. 72(5). 1651–1657. 34 indexed citations
12.
Andrew, M, Bosco Paes, Ruth Milner, et al.. (1988). Development of the human coagulation system in the healthy premature infant. Blood. 72(5). 1651–1657. 499 indexed citations breakdown →
13.
Andrew, M, et al.. (1987). Development of the human coagulation system in the full-term infant. Blood. 70(1). 165–172. 831 indexed citations breakdown →
14.
Levin, Marc, Richard M. Jay, Peter Powers, et al.. (1987). A DOUBLE BLIND RANDOMIZED TRIAL OF ORG 10172 LOW MOLECULAR WEIGHT HEPARINOID IN THE PREVENTION OF DEEP VEIN THROMBOSIS IN PATIENTS WITH THROMBOTIC STROKE. Thrombosis and Haemostasis. 58. 3 indexed citations
15.
Turpie, Alexander G.G., Mark Levine, Jack Hirsh, et al.. (1986). A Randomized Controlled Trial of a Low-Molecular-Weight Heparin (Enoxaparin) to Prevent Deep-Vein Thrombosis in Patients Undergoing Elective Hip Surgery. New England Journal of Medicine. 315(15). 925–929. 412 indexed citations
16.
Kelton, John G., et al.. (1985). Comparison of the measurement of surface or total platelet‐associated IgG in the diagnosis of immune thrombocytopenia. American Journal of Hematology. 18(1). 1–5. 23 indexed citations
17.
Kelton, John G., et al.. (1982). Drug-Induced Platelet Destruction. Seminars in Thrombosis and Hemostasis. 8(2). 116–137. 82 indexed citations
18.
Kelton, John G., et al.. (1981). Heparin Associated Thrombocytopenia Is Not A Typical Drug Induced Thrombocytopenia. Thrombosis and Haemostasis. 4 indexed citations
19.
Kelton, JG, et al.. (1980). Sex-related differences in platelet aggregation: influence of the hematocrit. Blood. 56(1). 38–41. 61 indexed citations
20.
Hull, R., D. Wayne Taylor, J. Hirsh, et al.. (1978). Impedance plethysmography: the relationship between venous filling and sensitivity and specificity for proximal vein thrombosis.. Circulation. 58(5). 898–902. 90 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026